{
    "clinical_study": {
        "@rank": "36678", 
        "arm_group": [
            {
                "arm_group_label": "Bupropion & Citalopram", 
                "arm_group_type": "Experimental", 
                "description": "100mg Bupropion & 20mg Citalopram taken orally one time per day or 100mg Bupropion & 10mg Citalopram taken orally one time per day or 50mg Bupropion & 20mg Citalopram taken orally one time per day 0r 50mg Bupropion & 10mg Citalopram taken orally one time per day"
            }, 
            {
                "arm_group_label": "Bupropion & Placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "100mg Bupropion & Placebo taken orally one time per day or 50mg Bupropion & Placebo taken orally one time per day"
            }, 
            {
                "arm_group_label": "Placebo & Citalopram", 
                "arm_group_type": "Active Comparator", 
                "description": "Placebo & 20mg Citalopram taken orally one time per day or Placebo & 10mg Citalopram taken orally one time per day"
            }, 
            {
                "arm_group_label": "Placebo & Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo & Placebo taken orally one time per day"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to document the clinical effects of bupropion and citalopram in\n      a single subject with Friedreich Ataxia."
        }, 
        "brief_title": "An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Friedreich Ataxia", 
        "condition_browse": {
            "mesh_term": [
                "Ataxia", 
                "Friedreich Ataxia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: N/A -\n\n        Exclusion Criteria: N/A\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01716221", 
            "org_study_id": "11-1141"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bupropion & Citalopram", 
                "intervention_name": "bupropion & Citalopram", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Bupropion & Placebo", 
                "intervention_name": "Bupropion & Placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo & Citalopram", 
                "intervention_name": "Placebo & Citalopram", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo & Placebo", 
                "intervention_name": "Placebo & Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citalopram", 
                "Bupropion", 
                "Dexetimide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "October 4, 2013", 
        "number_of_arms": "4", 
        "other_outcome": {
            "measure": "Hamilton Depression Rating Scale", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline and at 5, 10, 15, and 20 weeks"
        }, 
        "overall_official": {
            "affiliation": "University of Colorado, Denver", 
            "last_name": "Drew Kern, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "International Cooperative Ataxia Rating Scale (ICARS)", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline at 5, 10, 15, and 20 weeks"
            }, 
            {
                "measure": "Friedreich Ataxia Rating Scale (FARS)", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline at 5, 10, 15, and 20 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01716221"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Comparison of FARS and ICARS", 
            "safety_issue": "No", 
            "time_frame": "Baseline and weeks 5, 10, 15, and 20 scales"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}